MYCN gain and MYCN amplification in a stage 4S neuroblastoma
- 15 January 2003
- journal article
- case report
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 140 (2) , 157-161
- https://doi.org/10.1016/s0165-4608(02)00677-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Neuroblastoma with focal MYCN amplification and bone marrow infiltration: A staging and treatment dilemmaMedical and Pediatric Oncology, 2002
- Outcome of high‐risk neuroblastoma using a dose intensity approach: Improvement in initial but not in long‐term resultsMedical and Pediatric Oncology, 2001
- Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines*†Medical and Pediatric Oncology, 2001
- Combined M‐FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell linesGenes, Chromosomes and Cancer, 2001
- Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?Medical and Pediatric Oncology, 2001
- Germline duplication of chromosome 2p and neuroblastoma.Journal of Medical Genetics, 1997
- Stage IVS neuroblastoma: A clinical, histological, and biological analysis of 45 casesHuman Pathology, 1996
- Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?European Journal Of Cancer, 1995
- PCR assay for chromosome 1p deletion in small neuroblastoma samplesInternational Journal of Cancer, 1992
- SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSISThe Lancet, 1971